Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC
Mok, T.S.K., Lopes, G., Cho, B.C., Kowalski, D.M., Kasahara, K., Wu, Y.-L., de Castro, G., Turna, H.Z., Cristescu, R., Aurora-Garg, D., Loboda, A., Lunceford, J., Kobie, J., Ayers, M., Pietanza, M.C., Piperdi, B., Herbst, R.S.
Published in Annals of oncology (01.04.2023)
Published in Annals of oncology (01.04.2023)
Get full text
Journal Article
Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC
Mok, T.S.K, Wu, Y.-L., Kudaba, I., Kowalski, D.M., Cho, B.C., Turna, H.Z., de Castro, G., Srimuninnimit, V., Laktionov, K.K., Bondarenko, I., Kubota, K., Caglevic, C., Karaszewska, B., Dang, T., Yin, L., Penrod, J., Lopes, G.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
102OFinal analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC
Mok, T S K, Wu, Y-L, Kudaba, I, Kowalski, D M, Cho, B C, Turna, H Z, de Castro, G, Srimuninnimit, V, Laktionov, K K, Bondarenko, I, Kubota, K, Caglevic, C, Karaszewska, B, Dang, T, Yin, L, Penrod, J, Lopes, G
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
P-265THE ROLE OF SALVAGE LUNG RESECTION AFTER DEFINITIVE CHEMORADIATION THERAPY FOR STAGE IIIA (N2) NON-SMALL CELL LUNG CANCER
Turna, Akif, Yaksi, O, Kara, H V, Ersen, E, Turna, Z H, Dincbas, F, Erturan, S, Aydin, G, Kaynak, K
Published in Interactive cardiovascular and thoracic surgery (01.10.2017)
Published in Interactive cardiovascular and thoracic surgery (01.10.2017)
Get full text
Journal Article